조직 및 계약 가격을 보려면 로그인를 클릭합니다.
크기 선택
제품정보 (DICE 배송 시 비용 별도)
실험식(Hill 표기법):
C32H39NO4 · HCl
CAS 번호:
Molecular Weight:
538.12
UNSPSC Code:
12352200
PubChem Substance ID:
NACRES:
NA.77
MDL number:
제품 이름
Fexofenadine hydrochloride, >98% (HPLC)
SMILES string
Cl[H].CC(C)(C(O)=O)c1ccc(cc1)C(O)CCCN2CCC(CC2)C(O)(c3ccccc3)c4ccccc4
InChI key
RRJFVPUCXDGFJB-UHFFFAOYSA-N
InChI
1S/C32H39NO4.ClH/c1-31(2,30(35)36)25-17-15-24(16-18-25)29(34)14-9-21-33-22-19-28(20-23-33)32(37,26-10-5-3-6-11-26)27-12-7-4-8-13-27;/h3-8,10-13,15-18,28-29,34,37H,9,14,19-23H2,1-2H3,(H,35,36);1H
assay
>98% (HPLC)
form
powder
storage condition
desiccated
color
white to beige
solubility
DMSO: soluble ≥5 mg/mL
originator
Sanofi Aventis
storage temp.
−20°C
Quality Level
Gene Information
human ... HRH1(3269)
유사한 제품을 찾으십니까? 방문 제품 비교 안내
관련 카테고리
Application
Fexofenadine hydrochloride has been used as a non-cationic ampliphilic antihistamines in NCI-H661 cells and as a histamine H1 receptor antagonist in mice
Biochem/physiol Actions
Fexofenadine is used in treating allergic rhinitis and chronic idiopathic urticaria. It may give relief in bothersome symptom and is a second-generation antihistamines. Fexofenadine provides better relief compared to other antihistamines for nasal congestion. It is the active metabolite of terfenadine and bring down allergen-induced symptoms.
Fexofenadine is a non-sedating H1 histamine receptor antagonist.
Features and Benefits
This compound is a featured product for ADME Tox research. Click here to discover more featured ADME Tox products. Learn more about bioactive small molecules for other areas of research at sigma.com/discover-bsm.
This compound was developed by Sanofi Aventis. To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here.
저장 등급
11 - Combustible Solids
wgk
WGK 3
flash_point_f
Not applicable
flash_point_c
Not applicable
ppe
Eyeshields, Gloves, type N95 (US)
Effect of the second-generation antihistamine, fexofenadine, on cough reflex sensitivity and pulmonary function
Dicpinigaitis PV and Gayle YE
British Journal of Clinical Pharmacology, 56(5), 501-504 (2003)
Pharmacokinetics of fexofenadine: evaluation of a microdose and assessment of absolute oral bioavailability
Lappin G, et al.
European Journal of Pharmaceutical Sciences, 40(2), 125-131 (2010)
Repurposing cationic amphiphilic antihistamines for cancer treatment
Ellegaard AM, et al.
EBioMedicine, 9, 130-139 (2016)
Jae-Bong Kim et al.
Journal of neuroinflammation, 21(1), 53-53 (2024-02-22)
Parkinson's disease (PD) is a common and costly progressive neurodegenerative disease of unclear etiology. A disease-modifying approach that can directly stop or slow its progression remains a major unmet need in the treatment of PD. A clinical pharmacology-based drug repositioning
Inhibitory effect of oblongifolin C on allergic inflammation through the suppression of mast cell activation
Lu Y, et al.
Molecular and Cellular Biochemistry, 406(1-2), 263-271 (2015)
문서
Discover Bioactive Small Molecules for ADME/Tox
관련 콘텐츠
ADME/Tox를 위한 생체 활성 저분자
자사의 과학자팀은 생명 과학, 재료 과학, 화학 합성, 크로마토그래피, 분석 및 기타 많은 영역을 포함한 모든 과학 분야에 경험이 있습니다..
고객지원팀으로 연락바랍니다.